JP Morgan Maintains Overweight on Sempra, Lowers Price Target to $102
Benzinga Newsdesk 2 months ago
NewsPrice TargetAnalyst Ratings
JP Morgan analyst Aidan Kelly maintains Sempra (NYSE:SRE) with a Overweight and lowers the price target from $113 to $102.
JP Morgan analyst Aidan Kelly maintains Sempra (NYSE:SRE) with a Overweight and lowers the price target from $113 to $102.